QDossier Presenting on Registration and Impact of SmPC on Market Access

Regulatory approval does not ensure market access to a drug. Purchasing policy, reimbursement applications, and clinicians’ prescribing decisions are equally important to ensure drug accessibility to the patients.

Marloes will present the first module of the NEW Smelt Academy market access program. In that module, she will focus on the EU registration process of human medicines. Thereby she will do a deep dive into the development process of an SmPC and discuss the important role that SmPC-wording has down the line (e.g. market access).

This program is a combination of online meetings, preparatory assignments, and working on a personal case.

This program is intended for you if :

• You are now or in the future working in a pharmaceutical company.
• Customer-facing
• Need a broader understanding of drug access
• Professionals involved in a product launch

Speaker: Marloes van der Geer

Find more information here.